American International Group, Inc. Aptinyx Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.39 - $3.5 $47,525 - $69,597	-19,885 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$2.86 - $4.33 $148 - $225	52 Added 0.26%	19,885 $60,000
Q4 2020 Feb 12, 2021	BUY	$2.93 - $4.3 $13,732 - $20,154	4,687 Added 30.95%	19,833 $69,000
Q3 2020 Nov 04, 2020	BUY	$3.05 - $4.99 $387 - $633	127 Added 0.85%	15,146 $51,000
Q2 2020 Aug 12, 2020	BUY	$1.99 - $4.4 $29,887 - $66,083	15,019 New	15,019 $63,000
Q2 2019 Aug 13, 2019	SELL	$2.95 - $4.38 $25,995 - $38,596	-8,812 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$3.99 - $19.33 $191 - $927	48 Added 0.55%	8,812 $36,000
Q4 2018 Feb 13, 2019	SELL	$16.15 - $28.93 $1,114 - $1,996	-69 Reduced 0.78%	8,764 $145,000
Q3 2018 Nov 09, 2018	BUY	$20.21 - $31.85 $178,514 - $281,331	8,833 New	8,833 $256,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.